|
2022
|
Invention
|
Aminopyrazole derivatives as cdk7 inhibitors for use in treating in cancer. The present disclosur... |
|
|
Invention
|
1,2,4-oxadiazole and thiadiazole compounds as immunomodulators.
The present invention relates to... |
|
|
Invention
|
Imidazolidin-2-one compounds as prmt5 modulators.
The present invention relates to the derivativ... |
|
|
Invention
|
Cancer therapy using a combination of cdk7 inhibitor with an anti-cancer agent. |
|
|
Invention
|
Fused isoxazolyl compounds as kat6a inhibitors. The present invention provides fused isoxazolyl c... |
|
|
Invention
|
Process for preparing a cdk inhibitor. The present invention relates to the preparation of a CDK7... |
|
|
Invention
|
Substituted pyridazine compounds as cd73 inhibitors. The present invention provides pyridazine co... |
|
|
Invention
|
Substituted pyrazolyl compounds as malt-1 inhibitors. The present invention is directed to compou... |
|
2021
|
Invention
|
Cocrystal of a cdk inhibitor. The present invention relates to compound of formula (I) fumarate a... |
|
|
Invention
|
Cancer therapy using a combination of cdk7 inhibitor with an anti-microtubule agent. |
|
|
Invention
|
Heterocyclic compounds as cbp/ep300 bromodomain inhibitors. The present invention provides hetero... |
|
|
Invention
|
Method of treating cancer using fabp5 inhibitors. |
|
|
Invention
|
6-substituted pyridazine compounds as smarca2 and/or smarca4 degraders.
The present invention pr... |
|
|
Invention
|
6-substituted pyridazine compounds as smarca2 and/or smarca4 degraders. The present invention pro... |
|
|
Invention
|
Pharmaceutical compositions of a kinase inhibitor.
The present invention relates to pharmaceutic... |
|
|
Invention
|
Pharmaceutical compositions of a kinase inhibitor. The present invention relates to pharmaceutica... |
|
2020
|
Invention
|
Sulfonamide compounds targeting cd73 and adenosine receptors.
The present invention relates to b... |
|
|
Invention
|
Sulfonamide compounds targeting cd73 and adenosine receptors. The present invention relates to bi... |
|
|
Invention
|
Method for identifying responders to smarca2/4 degraders. The present invention relates to a meth... |
|
|
Invention
|
Substituted 5-cyclopropyl-1h-pyrazole-3-yl-amine derivatives as selective cdk12/13 inhibitors.
T... |
|
|
Invention
|
Substituted 5-cyclopropyl-1h-pyrazol-3-yl-amine derivatives as selective cdk12/13 inhibitors. The... |
|
2019
|
Invention
|
Substituted tetrahydroquinolinone compounds as ror gamma modulators. The present invention provid... |
|
|
Invention
|
Combination of small molecule cd-47 inhibitors with other anti-cancer agents. The present inventi... |
|
|
Invention
|
Pyridazine derivatives as smarca2/4 degraders.
The present invention provides pyridazine deri... |
|
|
Invention
|
Pyridazine derivatives as smarca2/4 degraders. The present invention provides pyridazine derivati... |
|
|
Invention
|
Substituted pyrazole derivatives as selective cdk12/13 inhibitors. The present invention provides... |
|
|
Invention
|
Imidazolidin-2-one compounds as prmt5 modulators. The present invention relates to the derivative... |
|
|
Invention
|
Substituted imidazolidin-2-one derivatives as prmt5 inhibitors. The present invention relates to ... |
|
|
Invention
|
Method of modulating tigit and pd-1 signalling pathways using 1,2,4-oxadiazole compounds. The pre... |
|
|
Invention
|
Substituted alkynylene compounds as anticancer agents. The present invention relates to substitut... |
|
|
Invention
|
1,2,4-oxadiazole compounds as inhibitors of cd47 signalling pathways. The present invention relat... |
|
2018
|
Invention
|
Dual inhibitors of tim-3 and pd-1 pathways. The present disclosure relates to 3-substituted 1,2,4... |
|
|
Invention
|
Conjoint therapies for immunomodulation. The present disclosure relates to methods comprising adm... |
|
|
Invention
|
Crystalline forms of 3-substituted 1,2,4-oxadiazole. The invention relates to crystalline forms o... |
|
|
Invention
|
Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors.
The present inv... |
|
|
Invention
|
Compounds and compositions for treating hematological disorders. The present invention provides m... |
|
|
Invention
|
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitor... |
|
2017
|
Invention
|
Spiro[cyclopentane-1,3'-indolin]-2'-one derivatives as bromodomain inhibitors. The present invent... |
|
2016
|
Invention
|
Indazole and azaindazole compounds as irak-4 inhibitors.
The present invention provides indazole... |
|
|
Invention
|
Substituted tetrahydroquinolinone compounds as ror gamma modulators.
The present invention provi... |
